BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32593830)

  • 1. COVID-19 cytokine storm and novel truth.
    Sultan S; Sultan M
    Med Hypotheses; 2020 Nov; 144():109875. PubMed ID: 32593830
    [No Abstract]   [Full Text] [Related]  

  • 2. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
    Yang MC; Tsai CC; Su YT; Wu JR
    Kaohsiung J Med Sci; 2021 Mar; 37(3):255-256. PubMed ID: 33400372
    [No Abstract]   [Full Text] [Related]  

  • 3. [What do we know about Kawasaki disease and COVID-19?].
    Hernandez Arias JJWA; Herrera de la Hoz RE; Lequerica Segrera PL
    Andes Pediatr; 2021 Apr; 92(2):281-287. PubMed ID: 34106169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
    Roshanravan N; Seif F; Ostadrahimi A; Pouraghaei M; Ghaffari S
    Arch Med Res; 2020 Oct; 51(7):608-612. PubMed ID: 32682575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm.
    Peng X; Wang Y; Xi X; Jia Y; Tian J; Yu B; Tian J
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):231-247. PubMed ID: 33404925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19].
    Muñoz-Jiménez A; Rubio-Romero E; Marenco de la Fuente JL
    Reumatol Clin (Engl Ed); 2021; 17(6):309-312. PubMed ID: 32482538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2019 Novel Coronavirus Pandemic: What Do We Know?
    Margallo LN; Diaz M; Lim PP
    S D Med; 2020 Jun; 73(6):262-264. PubMed ID: 32580258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A limited role of cytokine storm and fibrogenesis in COVID-19 related liver injury.
    Westerouen van Meeteren MJ; Van den Heuvel FM; Weijers G; Joosten LA; De Mast Q; Van de Veerdonk FL; Pickkers P; De Nooijer AH; Hoefsloot W; Drenth JP; De Korte CL; Nijveldt R; Netea MG; Tjwa ET
    J Gastrointestin Liver Dis; 2021 Mar; 30(1):166-168. PubMed ID: 33723544
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIMS-TS and Kawasaki Disease: The Mystery Deepens.
    Lutchman D
    Pediatr Infect Dis J; 2020 Aug; 39(8):e215-e216. PubMed ID: 32675759
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapies and COVID-19 related Neurological manifestations: A Comprehensive Review Article.
    Anwar MM
    J Immunoassay Immunochem; 2020 Nov; 41(6):960-975. PubMed ID: 33393415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.
    Luo W; Li YX; Jiang LJ; Chen Q; Wang T; Ye DW
    Trends Pharmacol Sci; 2020 Aug; 41(8):531-543. PubMed ID: 32580895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P, proinflammatory cytokines, transient receptor potential vanilloid subtype 1 and COVID-19: A working hypothesis.
    Aguirre-Siancas EE; Colona-Vallejos E; Ruiz-Ramirez E; Becerra-Bravo M; Alzamora-Gonzales L
    Neurologia (Engl Ed); 2021 Mar; 36(2):184-185. PubMed ID: 33160723
    [No Abstract]   [Full Text] [Related]  

  • 16. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Storm.
    Fajgenbaum DC; June CH
    N Engl J Med; 2020 Dec; 383(23):2255-2273. PubMed ID: 33264547
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19.
    Lin JH; Chen YC; Lu CL; Hsu YN; Wang WJ
    J Formos Med Assoc; 2020 Jun; 119(6):1116-1118. PubMed ID: 32359878
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy.
    Pensato U; Muccioli L; Cani I; Janigro D; Zinzani PL; Guarino M; Cortelli P; Bisulli F
    Ann Clin Transl Neurol; 2021 Apr; 8(4):968-979. PubMed ID: 33780166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.